Description
The c.1694G>T (p.Gly565Val) variant in LDLR gene, that encodes for low density lipoprotein receptor, has been identified in at least five individuals who fulfill the clinical criteria of Familial Hypercholesterolemia (FH) (PMID:12436241, 23375686, 32770674, 28161202). This variant has also been reported in homozygous/compound heterozygous (with p.Trp4*) status in individuals with severe FH (PMID: 27784735, 6299582). This variant has also been detected in hypercholesterolemia cohorts and cohorts referred for FH testing (PMID: 34037665, 34297352). Experimental studies on transfected CHO cells demonstrated that this variant caused complete retention of protein on the endoplasmic reticulum, severely affected LDLR surface expression, and no LDL particle internalization (PMID: 16740646, 16257961). In addition, studies on homozygous mutant cells showed LDLR activity of <2% compared to wild type (PMID: 1301956, 2901412, 6299582). In-silico computational prediction tools suggest that this variant may have deleterious effect on the protein function (REVEL score: 0.971). This variant is found to be absent in the general population database, gnomAD and interpreted as likely pathogenic/pathogenic by several submitters (10) in the ClinVar database (ClinVar ID: 3688). Other amino acid substitutions at the same codon (p.Gly565Arg, p.Gly565Asp, p.Gly565Ala) have been reported in individuals with FH (PMID: 33994402, 27784735, 11313767) and classified as likely pathogenic by ClinVar submitters (ClinVar ID: 1778186, 375819, 226366). Therefore, the c.1694G>T (p.Gly565Val) variant in LDLR gene is classified as likely pathogenic.
| # | Sample | Method | Observation |
|---|
| Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
|---|
| 1 | germline | unknown | 108544 | not provided | not provided | | 1 | not provided | not provided | not provided |
PubMed [ID: 1301956]